Skip to main content

Dietary calcium phosphate strongly impacts gut microbiome changes elicited by inulin and galacto-oligosaccharides consumption

Abstract

Background

Fructo-oligosaccharides (FOS), inulin, and galacto-oligosaccharides (GOS) are widely recognized prebiotics that profoundly affect the intestinal microbiota, including stimulation of bifidobacteria and lactobacilli, and are reported to elicit several health benefits. The combination of dietary FOS and inulin with calcium phosphate was reported to stimulate commensal Lactobacillus populations and protect the host against pathogenic Enterobacteriaceae, but little is known about the effects of GOS in diets with a different level of calcium phosphate.

Methods

We investigated the microbiome changes elicited by dietary supplementation with GOS or inulin using diets with high (100 mmol/kg) and low (30 mmol/kg) calcium phosphate levels in adult Wistar rats. Rats were acclimatized to the respective experimental diets for 14 days, after which fecal material was collected, DNA was extracted from fecal material, and the V3‑V4 region of the bacterial 16S rRNA gene was amplified with PCR, followed by microbial composition analysis. In tandem, the organic acid profiles of the fecal material were analyzed.

Results

Feeding rats non-supplemented (no prebiotic-added) diets revealed that diets rich in calcium phosphate favored members of the Firmicutes and increased fecal lactic, succinic, acetic, propionic, and butyric acid levels. In contrast, relatively low dietary calcium phosphate levels promoted the abundance of mucin degrading genera like Akkermansia and Bacteroides, and resulted in increased fecal propionic acid levels and modest increases in lactic and butyric acid levels. Irrespective of the calcium phosphate levels, supplementation with GOS or inulin strongly stimulated Bifidobacterium, while only high calcium phosphate diets increased the endogenous Faecalibaculum populations.

Conclusions

Despite the prebiotic’s substantial difference in chemical structure, sugar composition, oligomer size, and the microbial degradation pathway involved in their utilization, inulin and GOS modulated the gut microbiota very similarly, in a manner that strongly depended on the dietary calcium phosphate level. Therefore, our study implies that the collection of detailed diet information including micronutrient balance is necessary to correctly assess diet-driven microbiota analysis.

Video Abstract

Introduction

More than 2 decades ago, prebiotics were defined as: “a non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon, and thus improves health” [1]. Over the years, this definition has gone through several changes, to reach its recent, broader, and commonly accepted version in 2015: “a substrate that is selectively utilized by host micro-organisms conferring a health benefit.” Notably, this definition does no longer restrict prebiotics to food ingredients or intestinal applications, and provides no indication or direction for the health benefit, leaving a lot of freedom in the use of the term prebiotic [2]. Nevertheless, only a few compounds are considered established prebiotics [2, 3]. At present, the most commonly accepted prebiotic substrates are galacto-oligosaccharides (GOS) and the fructose-containing polymers fructo-oligosaccharides (FOS) and inulin. Inulin and FOS differ substantially in chemical composition, structure, and production methods from GOS [4,5,6] and therefore could potentially stimulate different microbiota members depending on the species- or strain-specific carbohydrate utilization repertoire [7, 8]. Inulin is composed of a series of linear β-2,1-linked fructose molecules with a terminal α-1,2-linked glucose moiety and occurs naturally in a wide variety of vegetables and has a varying degree of polymerization (DP), ranging from 2 to 60. FOS is derived from inulin through chemical or enzymatical conversions to result in a mixture of β-2,1-linked fructose molecules with either a terminal glucose or fructose moiety resulting in a substrate consisting of a substantially lower DP (DP2-10) [4]. Lactose-based GOS is industrially produced by various microbial β-galactosidases that when using high lactose concentrations produce a variety of galacto-oligosaccharides when using high lactose concentrations. The chemical complexity of these GOS preparations (i.e., linkage types, DP, degree of branching) depends on the reaction conditions and the β-galactosidase enzyme used, resulting in a variety of chemically diverse GOS preparations [5, 9]. GOS and inulin are renowned for their strong bifidogenic effect [10,11,12,13,14,15,16] and a more modest stimulation of intestinal lactobacilli [14, 15, 17,18,19]. These prebiotics, either on their own or in combination with probiotics (i.e., as a synbiotic) have been reported to contribute to various health benefits including improved immune function in elderly (i.e., GOS) [16, 18], reduced symptoms in inflammatory bowel syndrome [20], improved body-weight management or regulate satiety [21, 22], reduced symptoms in Crohn’s disease [23], and reduced mortality rate in newborn infants in rural India [24].

Intriguingly, dietary FOS has also been shown to increase pathogenic enterobacteria populations when supplemented in low-calcium phosphate diets [14, 25], and to increase the translocations and severity of infection of Salmonella enteriditis [26]. However, high calcium phosphate diets could counteract the FOS-induced stimulation of enterobacteria and colonic permeability [27], contributing to attenuation of infection and diarrhea symptoms in Salmonella and enterotoxigenic Escherichia coli (ETEC) challenged rats [14, 28, 29]. The modulation of the endogenous microbiota is evidently a primary quality of dietary prebiotics and dietary fiber, and is also known to be modulated by other macronutrients (e.g., dietary fat and protein intake) [3, 30,31,32]. However, modulation of the endogenous microbiota can also be influenced through micronutrients, including bio-available minerals such as calcium phosphate, magnesium, zinc and (heme-)iron, or vitamins [14, 28, 33,34,35,36]. It has been proposed that normally insoluble dietary calcium phosphate complexes can dissolve in the acidic environment of the GI-tract, resulting in increased buffering capacity in the intestinal lumen and contributing to the precipitation of cytotoxic surfactants like secondary bile acids [37,38,39]. Since Gram-positive bacteria have been suggested to be more susceptible to bile acids, the precipitation of bile acids by calcium phosphate supports various Gram-positive commensals like Lactobacillus and Bifidobacterium [40]. Additionally, diets high in calcium phosphate were also shown to protect against heme-induced (as proxy for red meat) colonic epithelial hyperproliferation that is associated with increased colon cancer risk [41, 42] and has been associated with intestinal mucin-degrading Akkermansia [35]. Consequently, the interplay of prebiotics with dietary calcium phosphate, as well as other macro- and micro- nutrients (e.g., heme), is an important decider in prebiotic effects on the intestinal microbiota and the associated beneficial versus detrimental health effects.

In this study, the modulatory effects of dietary inulin and GOS on the endogenous microbiota and fermentation metabolites in low and high calcium phosphate backgrounds were studied in adult male Wistar rats. Specific genera within the microbiota responded to the dietary modulations (i.e., prebiotic supplementation and calcium phosphate levels), revealing that GOS and inulin elicited highly comparable microbiota composition modulations that were strongly dependent on the calcium phosphate levels in the diet. Furthermore, supplementation with GOS and inulin resulted in dietary calcium phosphate-dependent changes in colonic organic acid profiles.

Materials and methods

Animal experiments and study design

Two independent animal experiments were performed, each using specific pathogen-free male Wistar rats (Harlen, Horst, The Netherlands) at 8 weeks of age, with an average body weight of 339 g ± 17. Upon arrival, rats were housed individually in standard rodent cages, in a temperature (22‑24 °C) and humidity (50‑60%) controlled environment with a 12-h light-dark cycle. During both trials, rats received food and water ad libitum, were weighed twice a week, and food intake was monitored daily. The rats (n = 8 per diet group) were fed powdered AIN-93-derived diets [43], with a high fat content (200 g fat/kg), to mimic the composition of a Western human diet and were acclimatized to housing conditions and the group specific diets for 14 days. The diets (Table 1) were supplemented with either 40 g/kg cellulose (Arbocel type B899 JRS, Zutphen, The Netherlands), 40 g/kg Orafti® GR Inulin (BENEO-Orafti, Oreye, Belgium), or 40 g/kg Vivinal GOS (Friesland Campina, Domo-branch, Amersfoort, the Netherlands) and contained either 30 or 100 mmol/kg (= 4.08 or 13.60 g/kg) CaHPO4 (calcium phosphate; CaPi) (Acros organics, Thermo Scientific). The experimental diets were designated as high CaPi with cellulose (Hca), high CaPi with GOS (HcaGOS), high CaPi with inulin (HcaInu), low CaPi with cellulose (Lca), low CaPi with GOS (LcaGOS), and low CaPi with inulin (LcaInu) (Figure SF1; Table ST1). The Lca, Hca, and HcaInu groups were included in both independent experiments, effectively generating two independent (n = 8) replicates for the Lca, Hca, and HcaInu groups. The low-CaPi diets reflect the lower range of habitual dietary calcium intake in many regions throughout Asia, Africa, and South America, while the high-CaPi diets reflect the upper boundaries of habitual dietary calcium intake in Northern European populations that consume increased amounts of dairy products that are rich in CaPi [27, 44, 45]. After the 14-day acclimatization period, fecal pellets were collected during the morning directly from individual rats. Fecal pellets were weighed (average of 100 mg) and homogenized after the addition of a fixed volume of PBS (1 or 2 mL) using a T10 basic ULTRA-TURRAX® (IKA-Werke, Staufen im Breisgau, Germany). Fecal slurries were aliquoted (aliquots of 250 or 500 μl, respectively) and stored at −80 °C for later analyses (see below).

Table 1 Composition of the experimental dietsa

Fecal DNA extraction

DNA was extracted from the fecal aliquots using the repeated bead beating method [46] and the QIAamp Fast DNA Stool Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer’s instruction. An average of 25 mg (standard deviation of 13 mg) of fecal sample (wet weight) was used as starting material for DNA extraction. Cells were lysed in Lysing Matrix B tubes prefilled with 0.1 mm silica beads (MP Biomedicals, Santa Ana, California, USA) using FastPrep-24TM (MP Biomedicals) at 5.5 m/s for 3 min (with intermittent cooling on ice in between after every minute). Subsequently, samples were heated at 95 °C for 15 min, supernatants were collected after centrifugation (10 min, 16 000 × g, 4 °C) and DNA was precipitated with 2.5 M ammonium acetate, followed by addition of one volume of isopropanol and incubated on ice for 30 min. Following precipitation, RNA and protein were removed from the samples by DNase-free RNase (10 mg/ml, Qiagen) and Proteinase K (Qiagen) treatment. Subsequently, DNA was purified using the QIAamp DNA Stool Mini Kit (Qiagen) as previously described [46]. DNA quality and quantity were determined using a Nanodrop DeNovix DS-11 spectrophotometer (DeNovix Inc., Wilmington, DE USA) and Qubit® 4 fluorometer (Thermo Fisher Scientific, Waltham, Massachusetts, USA) with the QubitTM dsDNA BR assay kit (Thermo Fisher Scientific), respectively. Total DNA yield resulted in an average of 1388 mg within a range of 232 to 3416 ng (data not shown), and for all samples PCR-amplicons were successfully obtained using the V3 and V4 primers.

Amplification and sequencing of 16s rRNA gene

The V3‑V4 region of the bacterial 16S rRNA gene was amplified with PCR using the 341F primer (5′ – CCTAYGGGRBGCASCAG – 3′) and the 806R primer (5′ – GGACTACNNGGGTATCTAAT – 3′) as specified by Novogene (https://en.novogene.com/services/research-services/metagenomics/16s-18s-its-amplicon-metagenomic-sequencing/). Purified amplicons were subjected to extension PCR using barcoded Illumina universal index sequencing adaptors prior to sequencing. Samples were sequenced (paired-end) using the Illumina MiSeq system (experiment 1) or Illumina Novoseq system (experiment 2) (performed by Novogene Co., Ltd., Beijing, China). Different sequencing techniques were used because in-house protocol changes at Novogene in between the execution of the two experiments. Paired-end reads were assigned to samples based on their unique barcode and truncated by cutting off the barcode and primer sequence.

Microbiota analysis

The analysis of the microbiome followed a previously proposed work-flow using the DADA2 package (v.1.12.1) [47] in R (v.3.6.1). Quality control included the filtering of low-quality reads, followed by read-dereplication, and amplicon sequence variants (ASVs) were inferred individually for forward and reverse reads. Subsequently, read-pairs with overlap were merged, while concatenating read pairs with overlap smaller than 12 base pairs. Singletons of concatenated reads were removed from further analysis to reduce computational intensity. Chimera removal was carried out and taxonomy was assigned using a 16S SILVA reference database (v.132). All previous steps leveraged the DADA2 package in R. The 16S rRNA amplicons were prepared, sequenced, and analyzed separately for the two independent experiments, as the difference in sequencing platform (MiSeq vs Novoseq) requires slightly different approaches in data processing. ASV calling was done with DADA2 with a post hoc work around to account for PHRED score quality binning in NovoSeq data that interferes with error model learning in DADA2. For this, the initially learned error model matrix was manually modified to ensure monotonicity for the error profile by clipping it to a maximum value, determined by the error frequency at Q40. For experiment 1 (MiSeq library), 4,200,134 reads were collected with an average of 131,254 reads per sample, and 4149 ASVs were detected (857 with ≥ 2 counts). For experiment 2 (Novoseq library), 3,959,851 reads were collected with an average of 98,996 reads per sample, and 3474 ASVs were detected (600 with ≥ 2 counts). For downstream analysis of the microbiota composition changes in the two experiments (separate or in combination; see the “Results” section), the ASV table was aggregated at phylum, family, and genus level and transformed into compositional values using phyloseq (version 1.28.0) [48] and microbiome packages (version 1.6.0) [49], discarding ASVs with a prevalence below 10%. For multivariate analysis at ASV level, ASV’s present in only a single sample and/or with a total count lower than 10 were discarded. For alpha diversity, the ASV table was filtered to contain at least 2 reads, no prevalence or variance filter was applied, rarified, and trimmed mean of M values (TMM) transformation was applied and Shannon diversity and Chao1 richness were calculated with the internal software in Microbiome Analyst [50]. Bray-Curtis dissimilarity was calculated in CANOCO 5 (Microcomputer Power, Ithaca, NY, USA) [51]. Compositional bar plots were created using ggplot2 (v.3.2.1) [52]. All scatter and boxplots for diversity indices, relative microbiota abundance, and fecal acid metabolite concentrations were created using GraphPad Prism version 8.2.1 for Windows (GraphPad Software).

Fecal organic acid quantification

For lactic and succinic acid determination by high performance liquid chromatography (HPLC), supernatants of the homogenized fecal aliquots (see sections above) were collected by centrifugation (10 min, 30 000 × g, room temperature). These fecal homogenate supernatants were injected (10 μL) using an Ultimate 3000 HPLC equipped with an autosampler, a RI-101 refractive index detector (Shodex, Kawasaki, Japan), and an ion-exclusion Aminex HPX-87 H column (7.8 mm × 300 mm) with a guard column (Bio-Rad, Hercules, CA, USA). Elution used 5 mM H2SO4 at a flow rate of 0.6 mL/min at an oven temperature of 65 °C. Calibration curves of lactic and succinic acid were prepared in a range of 0.01‑1 mg/mL. Chromeleon 7.2 software (Thermo Fischer Scientific) was used for data analysis.

The short chain fatty acids (SCFA), acetic, propionic, and butyric acid were quantified in aliquoted fecal samples (see sections above) by gas chromatography equipped with a flame ionization detector (GC-FID). Standard mixtures of acetic, propionic, and butyric acid in the concentration range of 0.01‑3 mg/mL were included in the analysis. Each sample was mixed in a 2:1 ratio with a solution containing HCl (0.3 M), oxalic acid (0.09 M) to fully protonate the organic acids, and the internal standard 2-ethyl butyric acid (0.45 mg/mL). The mixture was incubated for 30 min at room temperature and debris was removed by centrifugation (5 min, 15,000 × g, room temperature), and supernatants (0.3 μL) were injected in a CP-FFAP CB column (25 m × 0.53 mm × 1.00 μm) (Agilent Technologies, Santa Clara, CA, USA). The temperature profile during GC analysis was initiated with 30 s at 100 °C, followed by raising (8 °C/min) the temperature to 180 °C, which was maintained for 1 min followed by raising (20 °C/min) the temperature to 200 °C at 20 °C/min and maintaining this temperature for 5 min. Glass wool was inserted in the glass liner of the split injection port to protect the column from contamination [53]. The Xcalibur software (Thermo Fischer Scientific) was used for data analysis.

Statistical analysis

Significant differences between all groups for alpha and beta diversity were determined using Kruskal-Wallis ANOVAs with post hoc Dunn’s tests (α = 0.05) using Graphpad Prism version 8.00 for Windows (Graphpad Software). Significant differences between microbiota abundance and fecal acid profiles in the different groups of rats (supplemented versus non-supplemented within discriminant CaPi diet, and high- versus low-CaPi diets with analogous supplementation) were detected by a two-sided non-parametric Mann-Whitney U tests (α = 0.05) using GraphPad Prism version 8.00 for Windows (Graphpad Software). Principal component analyses (PCA) and partial redundancy analyses (pRDA) were performed in CANOCO 5, according to the user manual [51] with log transformed (Y′ = Y*1+1000) relative abundance at genus or ASV level. Arrows in PCA and pRDA plots correspond to microbial genera that are predicted to be correlated to environmental (or supplementary) variables. The top 10 genera with the largest contribution to the environmental variables in the ordination space were displayed. Significance of the explained variation was calculated by Holms corrected p value with α = 0.05.

Results

Animal experiments and study design

Eight-week-old male Wistar (n = 8 per group) rats were acclimatized to standardized AIN-93-based diets, supplemented with inulin, GOS, or cellulose with high or low CaPi for 2 weeks. Dietary groups included high CaPi (Hca), high CaPi with GOS (HcaGOS), high CaPi with inulin (HcaInu), low CaPi (Lca), low CaPi with GOS (LcaGOS), and low CaPi with inulin (LcaInu). The Hca, HcaInu, and Lca groups were involved in two independent experiments, resulting in two (n = 8) independent replicates (Figure SF1). Feed intake stabilized from an average consumption of approximately 19 g ± 5 to 17 g ± 1.5 a day during the 2-week acclimatization time. Average rat weight increased from 339 ± 17 to 381 ± 17 g with an average relative increase of bodyweight of 6.8% and 5.3% for the first and second week, respectively. Average weight between groups and relative weight increase throughout the trial did not differ significantly throughout the acclimatization period (Figure SF3).

Global microbiota composition across different dietary regimes

Comparing the microbiota composition of rats on dietary regimes without prebiotic supplementation (i.e., Hca and Lca diet groups) revealed that the Hca diet group was associated with increased relative abundance of the Firmicutes phylum, whereas increased relative abundance levels of Bacteroidetes and Verrucomicrobia were found in the Lca group (Fig. 1A; Figure SF2.A). Dietary supplementation with GOS or inulin resulted in an obvious increase in Actinobacteria, consisting entirely of Bifidobacteriaceae at family level, in both the high- and low-CaPi dietary background (Fig. 1A‑B; Figure SF2.A-B). In both CaPi backgrounds, the increase in Actinobacteria coincided with a decrease in relative abundance of the Firmicutes, which in the low-CaPi diets was accompanied by reduction of the relative abundances of Verrucomicrobia and Bacteroidetes. Particularly, within the Firmicutes phylum GOS or inulin supplementation resulted in distinct population shifts depending on the CaPi level of the diet. In both dietary CaPi regimes, GOS or inulin supplementation resulted in consistent decreases of Clostridiaceae_1, Peptostreptococcaceae and Ruminococcaceae, whereas Lachnospiraceae communities appeared to be much less affected. Notably, contrary to the decrease in relative abundance of the overall Firmicutes phylum, the high-CaPi diet supplementation with GOS or inulin drastically increased the relative abundance of the Erysipelotrichaceae within this phylum, which was not seen in the low-CaPi diets. The decrease in Verrucomicrobia and Bacteroidetes in the low-CaPi diets after prebiotic supplementation (i.e., GOS or inulin) is reflected by the decrease in Akkermansiaceae, Bacteroidaceae, and Muribaculaceae.

Fig. 1
figure1

Diet-group specific average composition of microbiota in adult rats after 14 days of dietary acclimatization. Stacked bar plots of relative abundance of endogenous microbiota at A phylum level, and B family level. Alpha diversity with C Shannon diversity and D Chao1 richness as diversity indices. E Beta diversity with the average Bray-Curtis distance of each sample within each dietary group. Statistical significance between groups is tested with a Kruskal-Wallis ANOVA followed post-hoc Dunn’s multiple comparison tests. Asterisks (*) indicate significance between groups with certain p values. *p < 0.05; **p< 0.01; ***p < 0.001; ****p < 0.0001. Samples derived from experiment 1 and experiment 2 (Fig. 1F) are colored orange and green, respectively. F pRDA of the microbiota with experiment as explanatory variable (corrected for diet) showing the 10 genera with the strongest contribution to the discrimination between independent experiments. G Partial principal component analysis (PCA) (corrected for experiment) displaying the top 10 most discriminating genera, with low-CaPi samples (circles), high-CaPi samples (squares), GOS supplementation (blue), inulin supplementation (red), or un-supplemented (yellow). Sample labels for experiment 1 and experiment 2 (Fig. 1F) contain an asterisk (*) or are empty, respectively

The genus-level microbiome alpha diversity (Shannon Diversity index) was not significantly different in the gut of rats of the Lca group compared to those of the Hca group. However, GOS or inulin supplementation significantly reduced the diversity, which was especially apparent in Hca diet groups, but was also detected to a lesser extent in the Lca groups (Fig. 1C). Conversely, when also taking richness into account (Chao1 index), these differences were much less pronounced, although the diversity was still slightly lower in rats that were fed the Lca diet compared to rats on Hca diet (Fig. 1D). Beta-diversity was significantly increased for all low-CaPi diets (i.e., Lca, LcaGOS, and LcaInu) compared to the HcaInu diet, but no differences were observed compared to the Hca and HcaGOS diets (Fig. 1E).

Because several dietary groups (i.e., Hca, Lca and HcaInu) are represented by groups of rats derived from independent experiments, we could assess the experimental variation using partial redundancy analysis (pRDA) corrected for diet and the “experiment” as explanatory variable (Fig. 1F). There is a significant link between experiment and microbiome composition (explained variation 8.7%, p = 0.0002). The difference between the independent experiments is largely driven by increased relative abundances of Parabacteroides, Ruminococcaceae_UCG-014 and an unknown genus in the second experiment, while the first experiment was characterized by higher relative abundances of Bacteroides and Blautia. Therefore, to avoid the results are confounded by the variations driven by the independent experiments, the “experiment” (first or second) was consistently corrected for as a co-variate in the downstream multivariate analyses.

To identify the strongest differentiating genera per dietary regime, a partial principal component analysis (PCA) at genus level shows a clearly separate clustering of the GOS or inulin supplemented diets relative to the un-supplemented diets (Lca or Hca) (Fig. 1G). The analysis did not separate microbiota composition clusters on basis of the prebiotic supplement used, but the exact way in which they are jointly different depends on the CaPi level of the diet. This result indicates that GOS and inulin supplementation elicit congruent effects on the microbiota composition in rats, but these effects are strongly dependent on the CaPi level of the diet. The microbiota observed in rats that were fed the background diets without supplementation (i.e., Lca and Hca groups) appeared to be only partially separated on basis of the CaPi level in this analysis, indicating that the microbiota impact of the dietary CaPi level is substantially smaller than the effect of the prebiotic supplementation, which strongly enhanced the distinction between the Lca and Hca groups irrespective of the prebiotic used. Notably, a partial PCA using ASV-level composition data provided similar results compared to analysis at genus level, with highly congruent relative positioning of the different diet groups and very similar explained variations (45.67% on X-axis versus 24.96% on Y-axis; data not shown).

Calcium phosphate is an important modulator of the endogenous microbiota

Since the modulatory effects of GOS and inulin seem to greatly depend on the CaPi levels in the diet, the primary differences in the high- and low-CaPi control diets (i.e., Hca and Lca groups) were further investigated to identify CaPi-dependent microbiota modulations. pRDA shows a strong link between microbiome composition and CaPi level (explained variation of 29.5%, p = 0.0002) (Fig. 2A). Increased relative abundance of the genera Ruminiclostridium_9, Roseburia, Erysipelatoclostridium, Ruminococcus_2, and Romboutsia is associated with the Hca diet group, whereas increased relative abundance of Bacteroides and Akkermansia is associated with the Lca diet group. Based on previously reported increased abundance of intestinal Lactobacillus populations in rats that were fed a high-CaPi diet [14, 28], we specifically analyzed this genus confirming that rats fed the Hca diet was correlating with higher relative abundances of Lactobacillus although the average relative abundance of this genus was relatively low (2.3% and 1.2% for Hca and Lca groups, respectively) (p value of 0.0012) (Fig. 2C). The impacts of dietary CaPi on the gut microbiota composition were largely conserved in rats that were fed the supplemented variants of these diets (i.e., LcaGOS and LcaInu versus HcaGOS and HcaInu). This is illustrated by the significant differences in Ruminoclostridium_9, Akkermansia, Bacteroides (Fig. 3A‑C), and the genera Romboutsia, Roseburia, and Erysipelatoclostrdium (Figure SF4) when comparing analogous Lca and Hca diets with the same supplementation, suggesting that the supplementation of GOS and inulin did not prominently alter CaPi-driven microbiota differences. In contrast, such conservation of CaPi effects on the microbiota were neither detected for Ruminococcus_2 (Figure SF4), nor for Lactobacillus, where the latter genus appeared to be particularly increased in several rats that were fed LcaGOS and LcaInu diets (Fig. 3D).

Fig. 2
figure2

Effect of dietary calcium phosphate on the microbiota. A pRDA for the explanatory variable CaPi (corrected for experiment) in the un-supplemented control diets Lca (circles) and Hca (squares), displaying the 10 most discriminative genera. The Hca versus Lca diet explains 29.46% of the microbiota variation (p value 0.002). Sample labels for experiment 1 and experiment 2 (Fig. 1F) contain an asterisk (*) or are empty, respectively. B Univariate analysis of the 9 named and most discriminative (ignoring the “unknown”) genera revealed by pRDA of the Hca (dark brown) and Lca (beige) diet groups. C Univariate analysis of Lactobacillus in Hca and Lca diet groups (p = 0.0012). Asterisks (*) indicate significance after a two-sided Mann-Whitney t test. *p < 0.05; **p < 001; ***p < 0.001; ****p < 0.0001; ns, not significant. Samples derived from experiment 1 and experiment 2 (Fig. 1F) are colored orange and green, respectively

Fig. 3
figure3

Univariate analysis of selected discriminant genera between dietary groups. Relative abundance of the genera A Ruminoclostridium, B Akkermansia, C Bacteroides, D Lactobacillus, E Bifidobacterium, and F Faecalibaculum in each dietary group. Asterisks (*) indicate significance after a two-sided Mann-Whitney t test. *p < 0.05; **p < 001; ***p < 0.001; ****p < 0.0001. Samples derived from experiment 1 and experiment 2 (Fig. 1F) are colored orange and green, respectively

GOS- or inulin-supplementation elicit congruent, calcium phosphate-dependent microbiota changes

To further investigate the effects of supplementation (i.e., GOS or inulin), we performed multivariate analyses of the un-supplemented and supplemented variants of the diets separately for the high and low-CaPi diets. In both the high and low-CaPi dietary background, supplementation with GOS or inulin had a very large and significant impact on the microbiota composition, explaining 57% and 44% of the variation in high and low-CaPi diets, respectively (Fig. 4A‑B). This analysis also revealed that only a modest separation between the two distinct supplements could be detected in either of the CaPi diet backgrounds (explaining less than 2% of the overall variation), which is also seen in the un-supplemented diet groups particularly for the low-CaPi diet. These observations indicate that GOS or inulin supplementation of the diet elicits very large but predominantly overlapping changes in the rat microbiome.

Fig. 4
figure4

Effect of prebiotic supplementation depending on the dietary calcium phosphate background. A Partial redundancy analysis (pRDA) for the explanatory variable of supplementation (i.e., GOS, inulin, or control) (corrected for experiment) in the high-CaPi diets: Hca (yellow squares), HcaGOS (blue squares), HcaInu (red squares). B Partial redundancy analysis (pRDA) for the explanatory variable of supplementation (i.e., GOS, inulin, or control) (corrected for experiment) in the low-CaPi diets: Lca (yellow circles), LcaGOS (blue circles), LcaInu (red circles). Sample labels for experiment 1 and experiment 2 (Fig. 1F) contain an asterisk (*) or are empty, respectively

Irrespective of the CaPi level in the diet, GOS or inulin supplementation resulted in a significantly increased relative abundance of the genus Bifidobacterium (ranging from 15 to 35%), although the effect size appeared to be larger in the low-CaPi diet background (Fig. 3E). In the high-CaPi diet background, the Bifidobacterium increase coincides with a parallel increase in relative abundance of the genus Faecalibaculum, which is not observed at all in the low-CaPi diet background (Fig. 3F). Notably, the increased abundance of the family Erysipelotrichaecea was virtually exclusively attributable to the increased abundance of the Faecalibaculum genus, whereas other members (e.g., Erysipelatoclostridium) of this family remained unaffected (Figs. 1B and SF3). An increase in relative abundances of the Lactobacillus genus was detected upon the GOS and inulin supplementation of the low-CaPi diet; however, this was only significant for GOS (p value of 0.02) and not for inulin (p value of 0.35) where the increase was driven by a few rats with very high abundance levels of this genus (10 to 30%). In addition, the relative abundance of Bacteroides increased in rats fed the inulin supplemented low-CaPi diet relative to its GOS supplemented counterpart, although no inulin-supplementation associated increase in Bacteroides was detectable when comparing to the un-supplemented control diet. Notably, the latter observation could in part be driven by differences detected in the two independent experiments that were part of in this study (see above and Fig. 1F). The expansion of Bifidobacterium (and Faecalibaculum in the Hca diets) upon GOS or inulin supplementation, goes at the expense of the relative abundances of Ruminoclostridium_9 (Fig. 3A) and the genera Erysipelatoclostridum, Roseburia, Ruminococcus_2, and Romboutsia (Figure SF4) in both the high- and low-CaPi diet groups, despite the significant association of these genera with the un-supplemented high-CaPi diet. In addition to these genera, also, the relative abundance of Akkermansia is reduced upon GOS or inulin supplementation to the low-CaPi diet, although the populations remain relatively high (approximately twofold reduction in relative abundance) (Fig. 3B). Similarly, the Blautia populations decreased upon GOS or inulin supplementation in low-CaPi diets, although these changes were not significant (Figure SF4). Finally, a decrease in Parabacteroides is seen in the low-CaPi group but seems an effect exclusive to experiment 2 (Figure SF4). Remarkably, our analyses establish that the genera that are the strongest discriminants in the microbiota comparison between high- and low-CaPi diets without supplementation are also the genera that are most strongly impacted by the addition of the GOS and inulin prebiotic supplements to these diets, which is apparently largely independent of the CaPi level of the diet. Additionally, the analyses underpin that the microbiota changes elicited by these prebiotic supplements largely overlap and are more or less indistinguishable when comparing the two prebiotic supplementations in the context of diets with the same dietary CaPi level. The latter conclusion is also supported by the absence of a significant link between microbiome at genus levels and supplement (p = 0.3). Thereby, these results establish that it does not matter whether GOS or inulin is used to supplement the diet in these experiments, but there is a significant and important prebiotic dependent co-modulation by the dietary CaPi level of the diet.

Prebiotic supplementation affects SCFA profiles in a calcium phosphate-dependent matter

The impact on the microbiota of the dietary variations (prebiotic and/or CaPi level) may be reflected by bacterial metabolite profiles, like the carbohydrate fermentation metabolites lactic, succinic, acetic, propionic, and butyric acid. Therefore, the fermentation product profiles were determined in the fecal samples for which also 16S rRNA data was analyzed (Table ST1). Comparing the control diets that were not supplemented with prebiotics (i.e., Hca and Lca diets), propionic acid was significantly elevated in the Lca diet compared to the Hca diet, while all other organic acid levels were detected at comparable levels (Fig. 5A). Supplementation with GOS and inulin in the high-CaPi diets, led to significant increases in all organic acid levels, with the strongest effect in the inulin supplemented diet (HcaInu) (Fig. 5A). These relatively consistent effects of prebiotic supplementation observed in the Hca diets are contrasted by the very modest effects of the same supplementations in the Lca diet. Propionic acid levels were predominantly increased in the LcaGOS and LcaInu diets, although modest increases were also seen in butyric acid and lactic acid, of which the latter was only significant in the LcaGOS diet (Fig. 5A). This CaPi-dependent contrast is also clearly reflected in the total amount of organic acids that are highly significantly increased in HcaGOS and HcaInu diets compared to the Hca diet, while in the low-CaPi context only, the LcaGOS displayed a modest increase in total fecal organic acid levels (Fig. 5A).

Fig. 5
figure5

Organic acid profiles in fecal samples. A Succinic, lactic, acetic, propionic, butyric, and total organic acid levels of fecal samples expressed in μmol/g feces (wet weight). Asterisks (*) indicate significance after a two-sided Mann-Whitney t test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Samples derived from experiment 1 and experiment 2 (Fig. 1F) are colored orange and green, respectively. B Partial redundancy analysis (pRDA) of microbiota at genus level with diet groups as explanatory variables with Hca (yellow squares), HcaGOS (blue squares), HcaInu (red squares), Lca (yellow circles), LcaGOS (blue circles), and LcaInu (red circles) and volatile acid profiles as supplementary variables with succinic acid (SA), lactic acid (LA), acetic acid (AA), propionic acid (PA), and butyric acid (BA). Partial redundancy analysis (pRDA) of microbiota at genus level with organic fecal acid concentrations as explanatory variable (corrected for experiment) showing the 10 most explanatory genera on the x-axis with C lactic acid (LA), D acetic acid (AA), and E propionic acid (PA). Sample labels for experiment 1 and experiment 2 (Fig. 1F) contain an asterisk (*) or are empty, respectively

pRDA with composition as response variable, diet as explanatory variable and organic acid profiles as supplementary variable reveals a correlation of propionic acid with the LcaGOS and LcaInu samples which are primarily associated with Akkermansia, Bifidobacterium, and Lactobacillus (Fig. 5B). Conversely, acetic and lactic acid are most abundant in the HcaGOS and HcaInu groups, associated with Faecalibaculum. The increase in succinic acid in the HcaGOS and HcaInu groups showed the smallest link to microbiome composition. Separate pRDAs, with individual acid levels as explanatory variable, indicate association of Lactobacillus, Faecalibaculum, and Bifidobacterium with increased lactic and acetic acid levels (Fig. 5C‑D). Furthermore, propionic acid levels are increased in samples with elevated Bacteroides, Lachnoclostridium, Akkermansia, and Bifidobacterium (Fig. 5E).

Discussion

In this study, we investigated the effect of dietary CaPi and prebiotic supplementation (i.e., GOS or inulin) on the modulation of the endogenous microbiota in rats. Our study shows that the CaPi background strongly influences gut microbiota composition, where diets high in CaPi favor the proliferation of several Firmicutes members (among others Romboutsia, Roseburia, Ruminoclostridium, and Ruminococcus), while diets low in CaPi predominantly favor Bacteroides and Akkermansia. Rats that were fed the un-supplemented high-CaPi diet also had a higher relative abundance of Lactobacillus relative to those on un-supplemented low-CaPi diets, which is in agreement with previous findings [14, 28]. The proposed proliferative effect of dietary CaPi on lactobacilli and bifidobacteria [28, 37, 38] likely extends to other Gram-positive gut commensals as is seen in the increase of various genera belonging to the Firmicutes phylum in the high-CaPi control diet, which contrasts with the low-CaPi diets that favors the Gram-negative Bacteroides and Akkermansia. These observations agree with the established role of CaPi in precipitation of secondary bile acids in the colon [37,38,39], creating physical-chemical conditions that are favoring the proliferation of Gram-positive bacteria [40]. Additionally, elevated levels of CaPi could contribute to the buffering capacity of the colon lumen, which may also affect the microbiota. These mechanisms of action of dietary CaPi are very likely to be conserved in humans, although there are to the best of our knowledge no reports dedicated to the investigation of the influence of dietary CaPi intake on human gut-microbiota composition.

The significant low-CaPi-related increase in intestinal Akkermansia is noteworthy, as this genus is a dedicated mucin degrader that can also stimulate mucus production, and is associated with improved insulin resistance and improved mucosal barrier function [54,55,56]. However, other studies have shown that a disbalance in Akkermansia populations can negatively affect mucosal barrier function, as is illustrated by the elevated Akkermansia levels associated with dietary heme supplementation in mice that was associated with disproportionate mucolysis and colonic epithelial hyperproliferation and reduced mucosal barrier function [35]. Similarly, gnotobiotic mice colonized with a synthetic commensal microbiota cocktail, containing among others Akkermansia muciniphila and several Bacteroides strains was shown to switch to degradation of the colonic mucus layer when deprived of dietary fiber, resulting in an increased susceptibility to pathogens that can traverse the mucosal barrier [57]. Interestingly, the same study also shows that diet-supplementation with purified soluble fibers, including inulin (as well as arabinoxylan and β-glucan), could barely mitigate the observed microbial erosion of the mucus layer, suggesting that complex plant-derived fibers are critical ingredients in the diet. Interestingly, Bacteroides thetaiotaomicron, when mono-associated in mice, metabolized predominantly the host mucus glycans only when the mice were fed a diet that lacked non-digestible plant-derived polysaccharides [58], underpinning the role of dietary fibers in modulation of not only the endogenous microbiota composition and activity but also its interaction with the host. Since the mucin-degrading bacteria Akkermansia and Bacteroides are enriched in our experimental rats fed a low-CaPi diet, it is tempting to speculate that the mucus layer is also thinner in these animals as compared to their high-CaPi diet counterparts, which is potentially compensated (in part) by prebiotic supplementation (i.e., GOS or inulin). The elevated levels of these bacterial groups in the low-CaPi-diet context are in good agreement with the significantly elevated levels of fecal propionic acid, which is a known fermentation product of these bacteria [59,60,61]. Since prebiotic supplementation (either GOS or inulin) in a low-CaPi-diet context led to a further elevation of propionic acid levels without strongly affecting the other organic acids, it is likely that these same bacterial groups are also involved in metabolization of these supplements. Therefore, our results suggest that CaPi could be a determinant for the consequences of prebiotic supplementation on the modulation of the microbiota and the organic acid profiles. Furthermore, such consequences could have an accessory impact on the host mucus layer. Analogous to what we concluded above, these findings clearly warrant human studies investigating the role of dietary CaPi in modulating the gut microbiota composition in combination with its effects on mucosal barrier function.

Supplementation with GOS and inulin-elicited congruent effects within each CaPi background. Both CaPi backgrounds facilitated large increases in local Bifidobacterium abundance which has been commonly observed for inulin and fructo-oligosaccharides (FOS) [13,14,15, 19, 62, 63] and GOS [10, 11]. Importantly, in our study, the increase of the Bifidobacterium genus in both the GOS and inulin supplemented diets is not attributable to different Bifidobacterium ASV’s for the two prebiotic substrates (data not shown), further supporting the congruent effects of GOS and inulin. Interestingly, only the high-CaPi background substantially elevated Faecalibaculum populations, suggesting that the Gram-positive Faecalibaculum may be particularly susceptible to (secondary) bile acid associated stress. GOS and inulin differ substantially in chemical structure and complexity [4, 5] and consequently also the mechanism of their degradation and utilization by members of the gut microbiome. Fructo-oligosaccharides (FOS) and inulin are regularly hydrolyzed extracellularly by bifidobacteria but the capacity to degrade FOS and inulin of different lengths is strain-dependent [64]. GOS utilization is diverse in Bifidobacterium and a multitude of extra- and intracellular hydrolases and import systems have been attributed to different species and have also shown to be strain specific [6, 65,66,67]. Lactobacilli have limited capacity to utilize GOS or inulin and commonly rely on intracellular GOS hydrolysis [68,69,70], and extracellular digestion of inulin has been described for several species [71,72,73]. GOS metabolism is often facilitated by ABC transporters and occasionally by lactose permeases in Bifidobacterium species [65, 66, 74], while several Lactobacillus species (i.e., L. acidophilus, L. reuteri and L. plantarum) employ lactose permeases for GOS import [68,69,70]. To the best of our knowledge, the mechanisms of GOS or inulin utilization in Faecalibaculum has not been described to date. Public genomes of Faecalibaculum rodentium encode secreted proteins with glycoside hydrolase (GH) family 32 domains that are commonly involved in inulin utilization [75]. There are no indications of extracellular GOS degradation in Faecalibaculum. However, Faecalibaculum rodentium genomes do encode lactose-PTS systems as well as genetically linked intracellular 6-P-β-galactosidases, which are functions that in Lactobacillus gasseri were shown to convey the ability to utilize GOS [76, 77]. Therefore, it is conceivable that Faecalibaculum can also utilize GOS through PTS-driven import. Moreover, since the bulk of the GOS constituents used in this study have a degree of polymerization of 3 to 4, they are likely not dependent on extracellular degradation, and thereby could readily stimulate Faecalibaculum growth. Additionally, due to declining lactase activity in maturing rats [78], lactose is poorly broken down and absorbed in the small intestine and may still stimulate the endogenous microbiota, including Faecalibaculum. Overall, it is clear that Faecalibaculum profits from the high-CaPi environment and is equipped to compete against endogenous Bifidobacteria in both prebiotic supplemented diets (i.e., HcaGOS and HcaInu diets). Intriguingly, it has been postulated that the obligate anaerobic Faecalibaculum rodentium can out-compete endogenous Lactobacillus and Bifidobacterium populations during gut maturation in rodents as the gut becomes more strictly anaerobic [79]. Notably, the murine Faecalibaculum rodentium and its human counterpart, Holdemanella biformis, were recently associated with anti-tumorigenic activity [80], potentiating their positive health benefits on both the murine and human host, respectively. Moreover, we have recently shown that the Hca diet favors the intestinal persistence of dietary lactobacilli (e.g., probiotics) compared to the Lca diet [73], further supporting the health-beneficial potential of high-CaPi diets. Contrary to the dietary lactobacilli, the endogenous intestinal lactobacilli were particularly enriched upon prebiotic supplementation in the low-CaPi diet background [73]. This result appears to be in contrast to previous reports about significantly increased Lactobacillus populations upon inulin supplementation in diets with either low- or high-CaPi levels [14]. Although the latter study used virtually identical CaPi regimes as we employed in the present study, the level of inulin supplementation was significantly higher (60 g/kg compared to 40 g/kg in the current study). It is possible that in our experiments the lower level of prebiotic-supplementation diminished the Lactobacillus stimulation effect observed earlier, possibly due to more stringent prebiotic substrate competition (i.e., in HcaGOS and HcaInu diets) by endogenous Bifidobacterium and Faecalibaculum populations.

Bifidobacterium, Faecalibaculum, and Lactobacillus are all lactic acid producers [79, 81, 82], but they can also produce acetic acid to a variable degree [79, 82,83,84]. The effect of GOS and inulin supplementation on organic acid profiles is very much CaPi dependent and increases in fecal lactic and acetic acid levels are especially associated with the supplemented high-CaPi diets. This is remarkable because the Bifidobacteria are greatly increased in diets supplemented with GOS or inulin irrespective of the CaPi level of the diet, while their signature metabolites (i.e., lactic and acetic acid) were predominately increased in the supplemented high-CaPi diets, although modestly increased levels of lactic acid were also detected in the low CaPi, GOS supplemented diet. Fecal measurements of organic acid profiles are straightforward and convenient and often determined in diet-intervention studies that employ carbohydrate supplementations. However, the dynamic process of organic acid nutrikinetics (i.e., the overall resultant of microbial production, host absorption, and bacterial cross-feeding) complicate their accurate interpretation in the context of dietary intervention and microbial composition and/or activity [85]. For example, another study that investigated the interplay between GOS and dietary CaPi collected proximal colonic contents instead of feces and concluded that high-CaPi regimes counteracted lactate and SCFA production [86], while our measurements from feces show the contrary. Nonetheless, the effect of dietary CaPi and prebiotic supplementation clearly influences the fecal organic acid levels, and the detected correlation of increased lactic and acetic acid with bacterial genera that produce these acids in high-CaPi diets is intriguing and suggests that these effects may also lead to a more acidified gut lumen, which could further influence the intestinal microbiota and its interaction with the host.

It is important to note that the interaction of CaPi and other (micro)nutrients is not restricted to prebiotics. Particularly, there are several reports on the role dietary CaPi can play in the suppression of colonic cytotoxicity levels that are associated with the consumption of heme (i.e., red meat) and that were shown to induce colonic epithelial hyperproliferation [41, 42, 87]. Human relevance of this activity of dietary CaPi is apparent from epidemiological evidence that establishes the association between the consumption of heme and an increased risk for the development of colon cancer [88, 89]. In the context of heme containing diets, high-CaPi levels comparable to the levels employed in this study, prevented the heme-induced cytolytic activity of fecal water in mice [41]. Strikingly, dietary heme also affects the microbiota leading to decreased Firmicutes and increased Bacteroidetes in the colon of mice, which was proposed to be related to the selective susceptibility of Gram-positive bacteria to the heme-induced cytotoxic fecal water [90]. Moreover, the heme-induced hyperproliferation was recently demonstrated to be dependent on the microbiota, identifying an association of the elevated levels of Akkermansia municiphila in the intestine of mice that were fed a heme-containing diet with disproportionate mucolysis and reduced mucosal barrier function, thereby potentiating colonic epithelial hyperproliferation and enhancing colon cancer risk [35]. The proposed role of CaPi in reducing the heme-induced cytotoxicity in the colon displays strong similarity with its precipitating effect on colonic secondary bile acids, which also suppresses the mucosa-damaging physical-chemical characteristics of the colon content, indicating a consistent mode of action of dietary CaPi in reducing colon cytotoxicity through the complexation of damaging components from the lumen content. These effects were mostly evidenced in rodent models, but probably are conserved in humans and other monogastric animals based on the conservation of the physical chemical processes involved. This notion is supported by the observations in human studies that have shown that high-CaPi diets are protective against ETEC-induced diarrhea [29] and are able to counteract the impairment of mucosal barrier function in individuals consuming a diet supplemented with high levels of FOS [15].

Taken together, dietary CaPi can significantly affect physical chemical conditions in the colon lumen, and in human studies was evidenced to protect against infection and barrier impairment associated with prebiotic consumption, as well as the reduction of colon cancer risk, particularly in association with the consumption of red meat (i.e., heme). The interaction of nutrients that can have potential negative health effects by their capacity to impair colonic barrier function (i.e., heme and FOS) with CaPi appears to be the common theme in these findings, where there is increasing evidence for a pivotal role of the microbiota in both the negative effects of some of these nutrients (i.e., heme) as well as the protective effect of supplementation with high levels of CaPi. This study exemplifies the important impact of dietary CaPi on the microbiota in rats and highlights the interaction of this micro-nutrient with prebiotic supplements in co-modulation of the intestinal microbiota, underpinning the need for similar human studies that also assess important gut-health parameters like fecal water cytotoxicity and colon barrier function.

Conclusions

Our study exemplifies that GOS or inulin supplementation has a profound and congruent effect on the endogenous microbiota and its fermentation output, which is strongly dependent on the dietary CaPi level. It is likely that the endogenous Bifidobacterium and Faecalibaculum members of the microbiota are the most effective utilizers of both these substrates despite the differences in their chemical structure and complexity. Nevertheless, the modulatory capacity of other candidate prebiotics may modulate the microbiota in a different manner, depending on the genus- and species-specific enzymatic repertoires of the endogenous microbiota members. The diet-related microbiota responsiveness is also strongly determined by the genera that are associated with the un-supplemented Hca and Lca diets (e.g., Ruminoccocus, Romboutsia, Ruminoclostridium, and Akkermansia), which appear to decrease in relative abundance to accommodate the prebiotic-induced proliferation of Bifidobacterium and Faecalibaculum. Our study concludes unequivocally that the gut ecosystem responsiveness is determined not only by specific nutrients or supplements (i.e., dietary fiber or prebiotics) but is also highly dependent on secondary micronutrients such as CaPi. In many cases, micronutrients can steer the dynamics of microbial gut populations in conjunction with the selective forces exerted by macronutrients, potentially stimulating commensals and pathogens in similar and/or distinct manners, which can lead to shifts in the microbial ecosystem balance that can have consequences for health. Our results underpin that further investigation of the interplay between macro- (fibers or prebiotics) and micronutrients is required to better predict the microbiome and physico-chemical responses to dietary interventions with functional ingredients like prebiotics.

Availability of data and materials

The 16S ribosomal RNA data used in this study was deposited at the European Nucleotide Archive (ENA) with the following accession numbers: ERS5847309 to ERS5847340 and ERS5847673 to ERS5847712, under study number PRJEB43382. A corresponding metadata sheet (Table ST1) is found in the supplementary materials.

References

  1. 1.

    Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr United States. 1995;125:1401–12.

    CAS  Google Scholar 

  2. 2.

    Bindels LB, Delzenne NM, Cani PD, Walter J. Opinion: towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12:303–10. Available from:. https://doi.org/10.1038/nrgastro.2015.47.

    CAS  Article  Google Scholar 

  3. 3.

    Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491–502. Available from:. https://doi.org/10.1038/nrgastro.2017.75.

    Article  PubMed  Google Scholar 

  4. 4.

    Kelly G. Inulin-type prebiotics - a review: Part 1. Altern Med Rev. 2009;14:36–55.

    PubMed  Google Scholar 

  5. 5.

    Van Leeuwen SS, Kuipers BJH, Dijkhuizen L, Kamerling JP. Comparative structural characterization of 7 commercial galacto-oligosaccharide (GOS) products. Carbohydr Res. 2016;425:48–58. Available from:. https://doi.org/10.1016/j.carres.2016.03.006.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Böger M, Van Leeuwen SS, Lammerts Van Bueren A, Dijkhuizen L. Structural identity of galactooligosaccharide molecules selectively utilized by single cultures of probiotic bacterial strains. J Agric Food Chem. 2019;67:13969–77.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  7. 7.

    Sims IM, Tannock GW. Galacto-and fructo-oligosaccharides utilized for growth by cocultures of bifidobacterial species characteristic of the infant gut. Appl Environ Microbiol. 2020;86:1–11.

    Article  Google Scholar 

  8. 8.

    Fehlbaum S, Prudence K, Kieboom J, Heerikhuisen M, van den Broek T, Schuren FHJ, et al. In vitro fermentation of selected prebiotics and their effects on the composition and activity of the adult gut microbiota. Int J Mol Sci. 2018;19:3097.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  9. 9.

    Fischer C, Kleinschmidt T. Synthesis of galactooligosaccharides in milk and whey: a review. Compr Rev Food Sci Food Saf. 2018;17:678–97.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Davis LMG, Martínez I, Walter J, Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol. 2010;144:285–92. Available from:. https://doi.org/10.1016/j.ijfoodmicro.2010.10.007.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourié B, et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr. 2004;80:1658–64.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Costalos C, Kapiki A, Apostolou M, Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev. 2008;84:45–9.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Kleessen B, Schwarz S, Boehm A, Fuhrmann H, Richter A, Henle T, et al. Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr. 2007;98:540–9.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Katan MB, Van Der Meer R. Dietary fructo-oligosaccharicles and inulin decrease resistance of rats to salmonella: protective role of calcium. Gut. 2004;53:530–5.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  15. 15.

    Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Katan MB, van der Meer R. Dietary fructooligosaccharides affect intestinal barrier function in healthy men. J Nutr. 2006;136:70–4.

    PubMed  Article  Google Scholar 

  16. 16.

    Vulevic J, Juric A, Walton GE, Claus SP, Tzortzis G, Toward RE, et al. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr. 2015;114:586–95.

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Azcarate-Peril MA, Ritter AJ, Savaiano D, Monteagudo-Mera A, Anderson C, Magness ST, et al. Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc Natl Acad Sci U S A. 2017;114:E367–75.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 2008;88:1438–46.

    CAS  PubMed  Google Scholar 

  19. 19.

    Kleessen B, Hartmann L, Blaut M. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr. 2001;86:291–300.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29:508–18.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PGB, Neyrinck AM, et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut. 2013;62:1112–21.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr. 2005;93:S157–61.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Steed H, MacFarlane GT, Blackett KL, Bahrami B, Reynolds N, Walsh SV, et al. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn’s disease. Aliment Pharmacol Ther. 2010;32:872–83.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Panigrahi P, Parida S, Nanda NC, Satpathy R, Pradhan L, Chandel DS, et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature. 2017;548:407–12. Available from:. https://doi.org/10.1038/nature23480.

    CAS  Article  Google Scholar 

  25. 25.

    Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Van Der Meer R. Dietary fructo-oligosaccharides dose-dependently increase translocation of salmonella in rats. J Nutr. 2003;133:2313–8.

    PubMed  Article  Google Scholar 

  26. 26.

    Bovee-Oudenhoven IMJ, Ten Bruggencate SJM, Lettink-Wissink MLG, Van Der Meer R. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats. Gut. 2003;52:1572–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Schepens MA, Schonewille AJ, Vink C. Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. Nutr Clin Pract. 2010;25:218–9.

    Article  Google Scholar 

  28. 28.

    Bovee-Oudenhoven IM, Wissink ML, Wouters JT, Van der Meer R. Dietary calcium phosphate stimulates intestinal lactobacilli and decreases the severity of as salmonella infection in rats. J Nutr. 1999;129:607–12.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Van Doesburg W, Witteman BJM, Van der Meer R. Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium. Gastroenterology. 2003;125:469–76.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Wolters M, Ahrens J, Romaní-Pérez M, Watkins C, Sanz Y, Benítez-Páez A, et al. Dietary fat, the gut microbiota, and metabolic health – a systematic review conducted within the MyNewGut project. Clin Nutr. 2019;38:2504–20.

    PubMed  Article  Google Scholar 

  31. 31.

    O’Keefe SJD. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 2016;13:691–706 Available from: https://doi.org/10.1038/nrgastro.2016.165.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  32. 32.

    Simpson HL, Campbell BJ. Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther. 2015;42:158–79.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Bovee-Oudenhoven IMJ, Termont DSML, Heidt PJ, Van Der Meer R. Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: additive effects of dietary lactulose and calcium. Gut. 1997;40:497–504.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Schepens MAA, Rijnierse A, Schonewille AJ, Vink C, Brummer RJM, Willemsen LEM, et al. Dietary calcium decreases but short-chain fructo-oligosaccharides increase colonic permeability in rats. Br J Nutr. 2010;104:1780–6.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Ijssennagger N, Belzer C, Hooiveld GJ, Dekker J, Van Mil SWC, Müller M, et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci U S A. 2015;112:10038–43.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Yang Q, Liang Q, Balakrishnan B, Belobrajdic DP, Feng QJ, Zhang W. Role of dietary nutrients in the modulation of gut microbiota: a narrative review. Nutrients. 2020;12:1–57.

    Google Scholar 

  37. 37.

    Govers MJAP, Termont DSML, Lapre JA, Kleibeuker JH, Vonk RJ, van der Meer R. Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res. 1996;56:3270–5.

    CAS  PubMed  Google Scholar 

  38. 38.

    Govers MJAP, Van Der Meer R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut. 1993;34:365–70.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Govers MJAP, Termont DSML, Van Aken GA, Van der Meer RV. Characterization of the adsorption of conjugated and unconjugated bile acids to insoluble, amorphous calcium phosphate. J Lipid Res. 1994;35:741–8. Available from:. https://doi.org/10.1016/S0022-2275(20)39170-7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev. 2005;29:625–51.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Sesink ALA, Termont DSML, Kleibeuker JH, Van der Meer R. Red meat and colon cancer: dietary haem-induced colonic cytotoxicity and epithelial hyperproliferation are inhibited by calcium. Carcinogenesis. 2001;22:1653–9.

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Pierre F, Taché S, Petit CR, Van der Meer R, Corpet DE. Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis. 2003;24:1683–90.

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–51.

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Balk EM, Adam GP, Langberg VN, Earley A, Clark P, Ebeling PR, et al. Global dietary calcium intake among adults: a systematic review. Osteoporos Int. 2017;28:3315–24.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Institute of Medicine (US) Committee to review dietary reference intakes for vitamin D and calcium. Tolerable upper intake levels: calcium and vitamin D. In: Ross A, Taylor C, Yaktine A, editors. Diet. Ref. Intakes Calcium Vitam. D. Washington: National Academies Press (US); 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK56058/.

    Google Scholar 

  46. 46.

    Yu Z, Morrison M. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques. 2004;36:808–12.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Callahan BJ, McMurdie PJ, Rose MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–3.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8:e61217.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  49. 49.

    Lathi L, Setti SA. Tools for microbiome analysis in R. Version 2.1.24. http://microbiome.github.com/microbiome. 2017.

    Google Scholar 

  50. 50.

    Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017;45:W180–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  51. 51.

    Braak CJF ter, Smilauer P. CANOCO reference manual and CanoDraw for Windows user’s guide: software for canonical community ordination (version 4.5). 33, Biometris (WU MAT), www.canoco.com; 2002. Available from: https://edepot.wur.nl/405659

  52. 52.

    Wickham H. ggplot2: elegant graphics for data analysis [Internet]. New York: Springer-Verlag; 2016. Available from: https://ggplot2.tidyverse.org

    Book  Google Scholar 

  53. 53.

    Zhao G, Nyman M, Jönsson JÅ. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed Chromatogr. 2006;20:674–82.

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110:9066–71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    van Passel MWJ, Kant R, Zoetendal EG, Plugge CM, Derrien M, Malfatti SA, et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One. 2011;6:e16876.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  56. 56.

    Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63:727–35.

    CAS  PubMed  Article  Google Scholar 

  57. 57.

    Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2017;167:1339–1353.e21.

    Article  CAS  Google Scholar 

  58. 58.

    Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science (80- ). 2005;307:1955–9.

    CAS  Article  Google Scholar 

  59. 59.

    Adamberg S, Tomson K, Vija H, Puurand M, Kabanova N, Visnapuu T, et al. Degradation of fructans and production of propionic acid by Bacteroides thetaiotaomicron are enhanced by the shortage of amino acids. Front Nutr. 2014;1:1–10.

    Article  CAS  Google Scholar 

  60. 60.

    Macy JM. The biology of gastrointestinal Bacteroides. Ann. 1979;33:561–94.

    CAS  Google Scholar 

  61. 61.

    Ouwerkerk JP, van der Ark KCH, Davids M, Claassens NJ, Finestra TR, de Vos WM, et al. Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Appl Environ Microbiol. 2016;82:6983–93.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Vandeputte D, Falony G, Vieira-Silva S, Wang J, Sailer M, Theis S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut. 2017;66:1968–74.

    CAS  PubMed  Article  Google Scholar 

  63. 63.

    Kolida S, Meyer D, Gibson GR. A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr. 2007;61:1189–95.

    CAS  PubMed  Article  Google Scholar 

  64. 64.

    Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S, et al. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol. 2005;71:6150–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  65. 65.

    O’Connell Motherway M, Kinsella M, Fitzgerald GF, Van Sinderen D. Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003. Microb Biotechnol. 2013;6:67–79.

    PubMed  Article  CAS  Google Scholar 

  66. 66.

    Andersen JM, Barrangou R, Hachem MA, Lahtinen SJ, Goh YJ, Svensson B, et al. Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactis Bl-04. BMC Genomics. 2013;14:1 Available from: BMC Genomics.

    Article  CAS  Google Scholar 

  67. 67.

    Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom H-J, Block DE, Mills DA. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol. 2013;33:262–70.

    CAS  PubMed  Article  Google Scholar 

  68. 68.

    Rattanapprasert M, van Pijkeren J-P, Ramer-Tait AE, Quintero M, Kok CR, Walter J, et al. Genes involved in galactooligosaccharide metabolism in Lactobacillus reuteri and their ecological role in the gastrointestinal tract. Appl Environ Microbiol. 2019;85:1–15.

    Article  Google Scholar 

  69. 69.

    Andersen JM, Barrangou R, Hachem MA, Lahtinen S, Goh YJ, Svensson B, et al. Transcriptional and functional analysis of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus. Proc Natl Acad Sci U S A. 2011;108:17785–90.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  70. 70.

    Fuhren J, Schwalbe M, Peralta-Marzal L, Rösch C, Schols HA, Kleerebezem M. Phenotypic and genetic characterization of differential galacto-oligosaccharide utilization in Lactobacillus plantarum. Sci Rep. 2020;10:1–11. Available from. https://doi.org/10.1038/s41598-020-78721-4.

    CAS  Article  Google Scholar 

  71. 71.

    Buntin N, Hongpattarakere T, Ritari J, Douillard FP, Paulin L, Boeren S, et al. An inducible operon is involved in inulin utilization in Lactobacillus plantarum strains, as revealed by comparative proteogenomics and metabolic profiling. Appl Environ Microbiol. 2017;83:1–13.

    Article  Google Scholar 

  72. 72.

    Goh YJ, Zhang C, Benson AK, Schlegel V, Lee JH, Hutkins RW. Identification of a putative operon involved in fructooligosaccharide utilization by Lactobacillus paracasei. Appl Environ Microbiol. 2006;72:7518–30.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  73. 73.

    Fuhren J, Schwalbe M, Rösch C, Nijland R, Wels M, Schols HA, et al. Dietary inulin increases Lactiplantibacillus plantarum strain Lp900 persistence in rats depending on the dietary-calcium level. Appl Environmental Microbiol. 2021;87:e00122–21.

  74. 74.

    Hinz SWA, Pastink MI, Van Den Broek LAM, Vincken JP, Voragen AGJ. Bifidobacterium longum endogalactanase liberates galactotriose from type I galactans. Appl Environ Microbiol. 2005;71:5501–10.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  75. 75.

    Lammens W, Le Roy K, Schroeven L, Van Laere A, Rabijns A, Van Den Ende W. Structural insights into glycoside hydrolase family 32 and 68 enzymes: functional implications. J Exp Bot. 2009;60:727–40.

    CAS  PubMed  Article  Google Scholar 

  76. 76.

    Honda H, Nagaoka S, Kawai Y, Kemperman R, Kok J, Yamazaki Y, et al. Purification and characterization of two phospho-β-galactosidases, LacG1 and LacG2, from Lactobacillus gasseri ATCC33323 T. J Gen Appl Microbiol. 2012;58:11–7.

    CAS  PubMed  Article  Google Scholar 

  77. 77.

    Maathuis AJH, van den Heuvel EG, Schoterman MHC, Venema K. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a 13C-labeling technique. J Nutr. 2012;142:1205–12.

    CAS  PubMed  Article  Google Scholar 

  78. 78.

    van de Heijning BJM, Kegler D, Schipper L, Voogd E, Oosting A, van der Beek EM. Acute and chronic effects of dietary lactose in adult rats are not explained by residual intestinal lactase activity. Nutrients. 2015;7:5542–55.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  79. 79.

    Lim S, Chang DH, Ahn S, Kim BC. Whole genome sequencing of “Faecalibaculum rodentium” ALO17, isolated from C57BL/6J laboratory mouse feces. Gut Pathog BioMed Central. 2016;8:3–9.

    Article  CAS  Google Scholar 

  80. 80.

    Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol. 2020;5:511–24. Available from:. https://doi.org/10.1038/s41564-019-0649-5.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  81. 81.

    Mayo B, Aleksandrzak-Piekarczyk T, Fernández M, Kowalczyk M, Álvarez-Martín P, Bardowski J. Updates in the metabolism of lactic acid bacteria. Biotechnol Lact Acid Bact. 2010:3–33. Available from. https://doi.org/10.1002/9780813820866.ch1.

  82. 82.

    Van Der Meulen R, Adriany T, Verbrugghe K, De Vuyst L. Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production. Appl Environ Microbiol. 2006;72:5204–10.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  83. 83.

    Oude Elferink SJWH, Krooneman J, Jan C, Spoelstra SF, Faber F, Elferink SO, et al. Anaerobic conversion of lactic acid to acetic acid and 1 , 2-propanediol Lactobacillus buchneri. Appl Environ Microbiol. 2001;67:125–32.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  84. 84.

    Da Cunha MV, Foster MA. Sugar-glycerol cofermentations in lactobacilli: the fate of lactate. J Bacteriol. 1992;174:1013–9.

    Article  Google Scholar 

  85. 85.

    Verbeke KA, Boobis AR, Chiodini A, Edwards CA, Franck A, Kleerebezem M, et al. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res Rev. 2015;28:42–66.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  86. 86.

    Overduin J, Schoterman MHC, Calame W, Schonewille AJ, Ten Bruggencate SJM. Dietary galacto-oligosaccharides and calcium: effects on energy intake, fat-pad weight and satiety-related, gastrointestinal hormones in rats. Br J Nutr. 2013;109:1338–48.

    CAS  PubMed  Article  Google Scholar 

  87. 87.

    van der Meer-van KC, Kramer E, Jonker-Termont D, Katan MB, van der Meer R, Keijer J. Differential gene expression in rat colon by dietary heme and calcium. Carcinogenesis. 2005;26:73–9.

    Article  CAS  Google Scholar 

  88. 88.

    Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer. 2002;98:241–56.

    CAS  PubMed  Article  Google Scholar 

  89. 89.

    Balder HF, De Vogel J, Jansen MCJF, Weijenberg MP, Van Den Brandt PA, Westenbrink S, et al. Heme and chlorophyll intake and risk of colorectal cancer in the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev. 2006;15:717–25.

    CAS  PubMed  Article  Google Scholar 

  90. 90.

    IJssennagger N, Derrien M, van Doorn GM, Rijnierse A, van den Bogert B, Müller M, et al. Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk. PLoS One. 2012;7:e49868.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Kerstin Holmgren, Gunilla Önning, and Niklas Larson from PROBI A/B for the fruitful discussions about the results obtained. Furthermore, we want to thank BENEO-Orafti and Friesland Campina DOMO for providing the inulin and Vivinal GOS, respectively. We are also grateful to the biotechnicians of the laboratory animal facility of the Wageningen University (Wageningen, The Netherlands) for their excellent technical assistance.

Funding

This work was financially supported by PROBI A/B, Lund, Sweden, without having a direct involvement in study design, data acquisition, data interpretation, and the decision to submit this work for publication.

Author information

Affiliations

Authors

Contributions

Conceptualization: JF, MK, HS. Data curation: JF, MS, JB. Formal analysis: JF, MS, CR, JB, HS, MK. Investigation: JF, MS, CR. Methodology: JF, MS, JB, CR. Software: MS, JB. Project administration: JF, MK. Resources: MK, HS. Supervision: MK, HS. Validation: JF, CR. Writing—original draft: JF, MK. Writing—review and editing: MS, CR, JB, HS. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Michiel Kleerebezem.

Ethics declarations

Ethics approval and consent to participate

All performed animal experiments related to this study were approved by the Central Authority for Scientific Procedures on Animals (CCD) in the Netherlands.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure SF1.

Experimental set up of animal trials. Two independent animal trials with A) Hca, HcaInu, Lca and LcaInu diets and B) Hca, HcaGOS, HcaInu, Lca and LcaGOS diets. All rats were acclimatized to the experimental diets fourteen days. Feed intake was monitored daily while animals were weighed twice per week. After the fourteen-day acclimatization period, fecal samples were collected for each rat. Figure SF2. Individual composition plots. Individual stacked bar plots of relative abundance of A) Phylum level and B) Family level. Figure SF3. Rat weight over time. Weight of individual rats and averages with SEM for each dietary group from day of arrival (day 0) to the day of fecal pellet collection (day 14) for A) Experiment 1, with rats on the Lca diet (grey circles), LcaInu diet (grey triangles), Hca diet (black circles), and HcaInu (black triangles), and B) Experiment 2, with rats on the Lca diet (grey circles), LcaGOS diet (grey squares), Hca diet (black circles), HcaGOS diet (black squares) and HcaInu diet (black triangles). Boxplots of average and individual relative weight increase of each rat from day 14 compared to day 0 for C) Experiment 1, and D) Experiment 2. Differences in relative weight increase for each group were not significant. Figure SF4. Univariate analysis of discriminant genera between dietary groups. Relative abundance of the genera Romboutsia, Roseburia, Blautia, Ruminococcus_2, Erysipelatoclostridium and Parabacteroides in each dietary group. Asterisks (*) indicate significance after a two-sided Mann-Whitney t-test. *: p < 0.05; **p: < 0.01; ***: p < 0.001; ****: p < 0.000. Samples derived from experiment 1 and experiment 2 (Fig. 1F) are colored orange and green, respectively. Supplemental Table ST1. Rat metadata and fecal organic acid levels. Rat metadata used in both studies, including sample alias and accession numbers as deposited in ENA, study numbers corresponding to ENA submissions, experiment numbers corresponding to the current manuscript, rat numbers, dietary supplementation and fecal acid concentrations. CaPi: Calcium phosphate; Hca: high CaPi; Lca: low CaPi; Inu: inulin; GOS: galacto-oligosaccharides; Cl: cellulose; SA: succinic acid; LA: lactic acid; AA: acetic acid; PA: propionic acid; BA: butyric acid.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fuhren, J., Schwalbe, M., Boekhorst, J. et al. Dietary calcium phosphate strongly impacts gut microbiome changes elicited by inulin and galacto-oligosaccharides consumption. Microbiome 9, 218 (2021). https://doi.org/10.1186/s40168-021-01148-0

Download citation

Keywords

  • Intestinal microbiota
  • Short chain fatty acids
  • Diet
  • Prebiotics
  • Calcium phosphate